| scholarly article | Q13442814 |
| P2093 | author name string | Shou-Chuan Shih | |
| Horng-Yuan Wang | |||
| Yi-Ching Wang | |||
| I-Shyan Sheen | |||
| Chien-Ming Chu | |||
| Kuo-Shyang Jeng | |||
| Po-Chuan Wang | |||
| Shu-Ling Gu | |||
| Wen-Hsing Chang | |||
| P2860 | cites work | Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis | Q24684263 |
| The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. | Q33301664 | ||
| Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis | Q34210479 | ||
| The prognostic molecular markers in hepatocellular carcinoma | Q34668320 | ||
| Molecular and biological properties of the vascular endothelial growth factor family of proteins | Q35313427 | ||
| Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer | Q36292182 | ||
| Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. | Q36292232 | ||
| Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients | Q36422753 | ||
| Endothelial cells and angiogenic growth factors in cancer growth and metastasis. Introduction | Q36630222 | ||
| Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer | Q38480006 | ||
| Angiogenesis and tumor metastasis | Q41724143 | ||
| Prognostic significance of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin in patients with resectable hepatocellular carcinoma after surgery | Q44926653 | ||
| Circulating vascular endothelial growth factor (VEGF) is a possible tumor marker for metastasis in human hepatocellular carcinoma | Q47866457 | ||
| Expression of vascular endothelial growth factor in human hepatocellular carcinoma | Q47872949 | ||
| Significance of vascular endothelial growth factor mRNA expression in invasion and metastasis of hepatocellular carcinoma | Q47912418 | ||
| Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver | Q47993681 | ||
| Serum vascular endothelial growth factor is often elevated in disseminated cancer. | Q48709403 | ||
| Expression of vascular endothelial growth factor in normal liver and hepatocellular carcinoma: an immunohistochemical study. | Q50950759 | ||
| Vascular endothelial growth factor serum concentrations in ovarian cancer. | Q53352265 | ||
| Expression of epidermal growth factor and fibroblast growth factor in human hepatocellular carcinoma: an immunohistochemical study | Q68264800 | ||
| Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract | Q70487576 | ||
| Prognostic value of vascular endothelial growth factor expression in gastric carcinoma | Q71018131 | ||
| Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor | Q71048188 | ||
| Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer | Q71052737 | ||
| Prognostic significance of pathologic features of hepatocellular carcinoma. A multivariate analysis of 278 patients | Q71067081 | ||
| Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma | Q71170321 | ||
| Arterial elements and perisinusoidal cells in borderline hepatocellular nodules and small hepatocellular carcinomas | Q71627798 | ||
| Phenotype changes in tumor vessels associated with the progression of hepatocellular carcinoma | Q72084406 | ||
| Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer | Q72410073 | ||
| Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma. Association with angiogenesis and tumor progression | Q73016350 | ||
| Is the p53 gene mutation of prognostic value in hepatocellular carcinoma after resection? | Q73180761 | ||
| Expression of platelet-derived endothelial cell growth factor and vascular endothelial growth factor in hepatocellular carcinoma and portal vein tumor thrombus | Q73370593 | ||
| A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma | Q73894686 | ||
| Increased expression of vascular endothelial growth factor in human hepatocellular carcinoma | Q73908738 | ||
| Serum vascular endothelial growth factor levels in various liver diseases | Q74331012 | ||
| Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors | Q74452524 | ||
| High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancer | Q74534930 | ||
| Increased expression of vascular endothelial growth factor is associated with tumor progression in hepatocellular carcinoma | Q77321925 | ||
| [Pathological diagnosis of hepatocellular carcinoma] | Q77403914 | ||
| Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients | Q77556943 | ||
| Vascular endothelial growth factor tightly regulates in vivo development of murine hepatocellular carcinoma cells | Q77598562 | ||
| Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease | Q77916781 | ||
| Elevation of serum level of vascular endothelial growth factor as a new predictor of recurrence and disease progression in patients with superficial urothelial cancer | Q77952107 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| hepatocellular carcinoma | Q1148337 | ||
| resectable hepatocellular carcinoma | Q19000460 | ||
| P304 | page(s) | 643-648 | |
| P577 | publication date | 2004-03-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Prognostic significance of preoperative circulating vascular endothelial growth factor messenger RNA expression in resectable hepatocellular carcinoma: a prospective study | |
| P478 | volume | 10 |
| Q37197025 | A Possible Role for TNF-α in Coordinating Inflammation and Angiogenesis in Chronic Liver Disease and Hepatocellular Carcinoma |
| Q36353516 | Anti-angiogenic treatment of gastrointestinal malignancies |
| Q35640101 | Antiangiogenic agents in advanced gastrointestinal malignancies: past, present and a novel future |
| Q37724256 | Beyond sorafenib: novel targeted therapies for advanced hepatocellular carcinoma |
| Q51356864 | Branched-chain amino acid deficiency stabilizes insulin-induced vascular endothelial growth factor mRNA in hepatocellular carcinoma cells. |
| Q37197262 | Clinical significance of vascular endothelial growth factor in hepatitis C related hepatocellular carcinoma in Egyptian patients |
| Q38155510 | Combination of local transcatheter arterial chemoembolization and systemic anti-angiogenic therapy for unresectable hepatocellular carcinoma |
| Q37015632 | Development of sorafenib and other molecularly targeted agents in hepatocellular carcinoma |
| Q99630344 | Differential expression of angiogenesis-related miRNAs and VEGFA in cirrhosis and hepatocellular carcinoma |
| Q38184582 | Dissecting signaling pathways in hepatocellular carcinoma: new perspectives in medical therapy |
| Q37290714 | Evolving therapies in the treatment of hepatocellular carcinoma |
| Q34382777 | Exploiting novel molecular targets in gastrointestinal cancers. |
| Q37814700 | Gemox: a widely useful therapy against solid tumors-review and personal experience |
| Q35698574 | HCC and angiogenesis: possible targets and future directions |
| Q33695543 | Hedgehog inhibition reduces angiogenesis by downregulation of tumoral VEGF-A expression in hepatocellular carcinoma |
| Q37924314 | Hepatocellular carcinoma and vitamin D: a review |
| Q39307416 | Hepatocellular carcinoma treatment: a comparative review of emerging growth factor receptor antagonists |
| Q34605633 | Immunohistochemical assessment of angiogenesis in hepatocellular carcinoma and surrounding cirrhotic liver tissues |
| Q38074429 | New agents on the horizon in hepatocellular carcinoma |
| Q37463744 | Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis |
| Q38188582 | Review of angiogenesis in hepatocellular carcinoma |
| Q37584706 | Serum VEGF level is associated with the outcome of patients with hepatocellular carcinoma: a meta-analysis |
| Q35092548 | Suppression of angiogenesis and tumor growth in vitro and in vivo using an anti-angiopoietin-2 single-chain antibody |
| Q26865844 | Systemic therapy of hepatocellular carcinoma: current status and future perspectives |
| Q35913461 | Systemic treatment and targeted therapy in patients with advanced hepatocellular carcinoma |
| Q38149819 | Targeted therapy for advanced hepatocellular cancer in the elderly: focus on sorafenib |
| Q35000785 | Targeting metastatic upper gastrointestinal adenocarcinomas |
| Q37564297 | Vascular endothelial growth factor in the management of hepatocellular carcinoma: a review of literature |
Search more.